ELUT Q4 2023 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-53.6% YoY

Gross Profit

$2M36.2% margin

Operating Income

-$9M-144.8% margin

Net Income

-$9M-158.5% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

-4.1%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$43M

Total Liabilities

$82M

Stockholders' Equity

-$39M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$13M	-53.6%
Gross Profit	$2M	$5M	-57.4%
Operating Income	-$9M	-$9M	+3.8%
Net Income	-$9M	-$5M	-71.2%